{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:33:51Z","timestamp":1784547231018,"version":"3.55.0"},"reference-count":55,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2017,12,19]]},"DOI":"10.3233\/jad-170736","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T10:11:42Z","timestamp":1512468702000},"page":"571-580","source":"Crossref","is-referenced-by-count":45,"title":["Alterations in Acrolein Metabolism Contribute to Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"61","author":[{"given":"Han-Hsing","family":"Tsou","sequence":"first","affiliation":[{"name":"Institute of Environmental and Occupational Health Sciences, National Yang-Ming University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chin","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, National Yang-Ming University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Ling","family":"Fuh","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan"},{"name":"Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"Brain Research Center, National Yang-Ming University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Pin","family":"Chen","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan"},{"name":"Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"Brain Research Center, National Yang-Ming University, Taipei, Taiwan"},{"name":"Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Yun","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Environmental and Occupational Health Sciences, National Yang-Ming University, Taipei, Taiwan"},{"name":"Institute of Food Safety and Health Risk Assessment, National Yang-Ming University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Tsui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, National Yang-Ming University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-170736_ref1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3233\/JAD-130881","article-title":"Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer\u2019s disease","volume":"38","author":"Gainotti","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170736_ref2","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1212\/01.wnl.0000240127.89601.83","article-title":"Aging of the brain, entropy, and Alzheimer disease","volume":"67","author":"Drachman","year":"2006","journal-title":"Neurology"},{"key":"10.3233\/JAD-170736_ref3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.3233\/JAD-170736_ref4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JAD-2010-091501","article-title":"Plasma amyloid-beta forms in Alzheimer\u2019s disease and non-Alzheimer\u2019s disease patients","volume":"21","author":"Le Bastard","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170736_ref5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jalz.2008.10.004","article-title":"Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer\u2019s disease","volume":"5","author":"Roher","year":"2009","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-170736_ref6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.55782\/ane-2005-1544","article-title":"Plasma levels of alpha beta peptides are altered in amnestic mild cognitive impairment but not in sporadic Alzheimer\u2019s disease","volume":"65","author":"Sobow","year":"2005","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"10.3233\/JAD-170736_ref7","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1001\/archneur.60.7.958","article-title":"Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels","volume":"60","author":"Fukumoto","year":"2003","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-170736_ref8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jama.2010.1995","article-title":"Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline","volume":"305","author":"Yaffe","year":"2011","journal-title":"JAMA"},{"key":"10.3233\/JAD-170736_ref9","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3233\/JAD-2010-090249","article-title":"Plasma amyloid-beta as a biomarker in Alzheimer\u2019s disease: The AIBL study of aging","volume":"20","author":"Lui","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170736_ref10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archneur.64.3.354","article-title":"Association of low plasma Abeta42\/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease","volume":"64","author":"Graff-Radford","year":"2007","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-170736_ref11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/archneur.57.1.100","article-title":"Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease","volume":"57","author":"Mehta","year":"2000","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-170736_ref12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/1874467211003020066","article-title":"Potential role of acrolein in neurodegeneration and in Alzheimer\u2019s disease","volume":"3","author":"Dang","year":"2010","journal-title":"Curr Mol Pharmacol"},{"key":"10.3233\/JAD-170736_ref13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3233\/JAD-2010-100405","article-title":"Role of by-products of lipid oxidation in Alzheimer\u2019s disease brain: A focus on acrolein","volume":"21","author":"Singh","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170736_ref14","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.freeradbiomed.2010.02.016","article-title":"Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease","volume":"48","author":"Bradley","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.3233\/JAD-170736_ref15","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1046\/j.1471-4159.1999.0720751.x","article-title":"Protein-bound acrolein: A novel marker of oxidative stress in Alzheimer\u2019s disease","volume":"72","author":"Calingasan","year":"1999","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-170736_ref16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/mnfr.200700412","article-title":"Acrolein: Sources, metabolism, and biomolecular interactions relevant to human health and disease","volume":"52","author":"Stevens","year":"2008","journal-title":"Mol Nutr Food Res"},{"key":"10.3233\/JAD-170736_ref17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/toxsci\/kfu233","article-title":"Molecular mechanisms of acrolein toxicity: Relevance to human disease","volume":"143","author":"Moghe","year":"2015","journal-title":"Toxicol Sci"},{"key":"10.3233\/JAD-170736_ref18","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/mnfr.201100279","article-title":"Acrolein - a pulmonary hazard","volume":"55","author":"Bein","year":"2011","journal-title":"Mol Nutr Food Res"},{"key":"10.3233\/JAD-170736_ref19","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/mnfr.201100068","article-title":"Protein-conjugated acrolein as a biochemical marker of brain infarction","volume":"55","author":"Igarashi","year":"2011","journal-title":"Mol Nutr Food Res"},{"key":"10.3233\/JAD-170736_ref20","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1021\/tx900147g","article-title":"Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: Nucleophilic targets and adduct formation","volume":"22","author":"LoPachin","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.3233\/JAD-170736_ref21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/toxsci\/57.1.6","article-title":"The molecular effects of acrolein","volume":"57","author":"Kehrer","year":"2000","journal-title":"Toxicol Sci"},{"key":"10.3233\/JAD-170736_ref22","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1021\/tx800465m","article-title":"Protein modification by acrolein: Formation and stability of cysteine adducts","volume":"22","author":"Cai","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.3233\/JAD-170736_ref23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0378-4274(02)00055-3","article-title":"Acrolein causes transcriptional induction of phase II genes by activation of Nrf2 in human lung type II epithelial (A549) cells","volume":"132","author":"Tirumalai","year":"2002","journal-title":"Toxicol Lett"},{"key":"10.3233\/JAD-170736_ref24","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.taap.2005.12.013","article-title":"Upregulation of endothelial heme oxygenase-1 expression through the activation of the JNK pathway by sublethal concentrations of acrolein","volume":"214","author":"Wu","year":"2006","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.3233\/JAD-170736_ref25","doi-asserted-by":"crossref","first-page":"19666","DOI":"10.1074\/jbc.M611527200","article-title":"Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-kappaB1 DNA binding domain","volume":"282","author":"Lambert","year":"2007","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-170736_ref26","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jaci.2005.05.046","article-title":"Acrolein in cigarette smoke inhibits T-cell responses","volume":"116","author":"Lambert","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.3233\/JAD-170736_ref27","first-page":"110","article-title":"Metabolism and distribution of [2,3-14C]acrolein in Sprague-Dawley rats. II. Identification of urinary and fecal metabolites","volume":"43","author":"Parent","year":"1998","journal-title":"Toxicol Sci"},{"key":"10.3233\/JAD-170736_ref28","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/(SICI)1099-1263(199609)16:5<449::AID-JAT369>3.0.CO;2-9","article-title":"Metabolism anddistribution of [2,3-14C]acrolein in Sprague-Dawley rats","volume":"16","author":"Parent","year":"1996","journal-title":"J\u00a0Appl Toxicol"},{"key":"10.3233\/JAD-170736_ref29","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1042\/bj1341093","article-title":"Biosynthesis of mercapturic acids from allylalcohol, allyl esters and acrolein","volume":"134","author":"Kaye","year":"1973","journal-title":"Biochem J"},{"key":"10.3233\/JAD-170736_ref30","first-page":"986","article-title":"Quantitation of acrolein-derived(3-hydroxypropyl)mercapturic acid in human urine by liquidchromatography-atmospheric pressure chemical ionization tandemmass spectrometry: Effects of cigarette smoking","volume":"20","author":"Carmella","year":"2007","journal-title":"Chem ResToxicol"},{"key":"10.3233\/JAD-170736_ref31","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00702-007-0789-2","article-title":"In parkinsonian substantia nigra,alpha-synuclein is modified by acrolein, a lipid-peroxidationproduct, and accumulates in the dopamine neurons with inhibitionof proteasome activity","volume":"114","author":"Shamoto-Nagai","year":"2007","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JAD-170736_ref32","doi-asserted-by":"crossref","first-page":"45741","DOI":"10.1038\/srep45741","article-title":"Acrolein acts as a neurotoxin in the nigrostriatal dopaminergic system of rat: Involvement of alpha-synuclein aggregation and programmed cell death","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-170736_ref33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cca.2015.07.017","article-title":"Evaluation of dementia by acrolein, amyloid-beta and creatinine","volume":"450","author":"Igarashi","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.3233\/JAD-170736_ref34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-170736_ref35","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bbrc.2016.03.137","article-title":"Aggravation of brain infarction through an increase in acrolein production and a decrease in glutathione with aging","volume":"473","author":"Uemura","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-170736_ref36","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.jchromb.2009.09.003","article-title":"Determination of sixhydroxyalkyl mercapturic acids in human urine using hydrophilicinteraction liquid chromatography with tandem mass spectrometry(HILIC-ESI-MS\/MS)","volume":"878","author":"Eckert","year":"2010","journal-title":"J Chromatogr B Analyt Technol Biomed LifeSci"},{"key":"10.3233\/JAD-170736_ref37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/(SICI)1099-0801(199803\/04)12:2<47::AID-BMC717>3.0.CO;2-Y","article-title":"Simultaneous determination of creatine, uric acid, creatinine and hippuric acid in urine by high performance liquid chromatography","volume":"12","author":"Yang","year":"1998","journal-title":"Biomed Chromatogr"},{"key":"10.3233\/JAD-170736_ref38","doi-asserted-by":"crossref","first-page":"16058","DOI":"10.1074\/jbc.273.26.16058","article-title":"Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins","volume":"273","author":"Uchida","year":"1998","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-170736_ref39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3233\/JAD-2012-120253","article-title":"Increased protein-conjugated acrolein and amyloid-beta40\/42 ratio in plasma of patients with mild cognitive impairment and Alzheimer\u2019s disease","volume":"32","author":"Waragai","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170736_ref40","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00204-015-1517-6","article-title":"Biomarkers of lipid peroxidation in Alzheimer disease (AD): An update","volume":"89","author":"Bradley-Whitman","year":"2015","journal-title":"Arch Toxicol"},{"key":"10.3233\/JAD-170736_ref41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-170736_ref42","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cca.2014.01.007","article-title":"Distinction between mild cognitive impairment and Alzheimer\u2019s disease by CSF amyloid beta40 and beta42, and protein-conjugated acrolein","volume":"430","author":"Mizoi","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.3233\/JAD-170736_ref43","doi-asserted-by":"crossref","unstructured":"Anoop A , Singh PK , Jacob RS , Maji SK (2010) CSF biomarkers for Alzheimer\u2019s disease diagnosis. Int J Alzheimers Dis 2010, pii: 606802.","DOI":"10.4061\/2010\/606802"},{"key":"10.3233\/JAD-170736_ref44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jns.2011.11.001","article-title":"Peripheral markers in neurodegenerative patients and their first-degree relatives","volume":"314","author":"Cristalli","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-170736_ref45","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/10715760701861373","article-title":"Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer\u2019s disease from Mild Cognitive Impairment","volume":"42","author":"Bermejo","year":"2008","journal-title":"Free Radic Res"},{"key":"10.3233\/JAD-170736_ref46","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cca.2014.12.023","article-title":"Distinguishing mild cognitive impairment from Alzheimer\u2019s disease with acrolein metabolites and creatinine in urine","volume":"441","author":"Yoshida","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.3233\/JAD-170736_ref47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s002239900576","article-title":"Age-related changes in body composition, hydroxyproline, and creatinine excretion in normal women","volume":"64","author":"Worsfold","year":"1999","journal-title":"Calcif Tissue Int"},{"key":"10.3233\/JAD-170736_ref48","first-page":"233","article-title":"Changes in endogenouscreatinine clearance in man on acontrolled protein diet: Effectof route of administration of a protein load","volume":"13","author":"Penner","year":"1990","journal-title":"Clin InvestMed"},{"key":"10.3233\/JAD-170736_ref49","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0022-3476(98)70107-6","article-title":"The impact of dietary protein intake on urinary creatinine excretion in a healthy pediatric population","volume":"133","author":"Neubert","year":"1998","journal-title":"J Pediatr"},{"key":"10.3233\/JAD-170736_ref50","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1289\/ehp.7337","article-title":"Urinary creatinine concentrations in the U.S. population: Implications for urinary biologic monitoring measurements","volume":"113","author":"Barr","year":"2005","journal-title":"Environ Health Perspect"},{"key":"10.3233\/JAD-170736_ref51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00378371","article-title":"Reliability of urinary creatinine as a parameter used to adjust values of urinary biological indicators","volume":"55","author":"Alessio","year":"1985","journal-title":"Int Arch Occup Environ Health"},{"key":"10.3233\/JAD-170736_ref52","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jcf.2010.02.004","article-title":"The applicability of urinary creatinine as a method of specimen normalization in the cystic fibrosis population","volume":"9","author":"Wagner","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.3233\/JAD-170736_ref53","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2215\/CJN.02870707","article-title":"Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C","volume":"3","author":"Baxmann","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.3233\/JAD-170736_ref54","first-page":"F632","article-title":"Estimated lean body mass as an index for normalization of body fluid volumes in humans","volume":"247","author":"Boer","year":"1984","journal-title":"Am J Physiol"},{"key":"10.3233\/JAD-170736_ref55","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1089\/neu.2013.2888","article-title":"Determination of urine 3-HPMA, a stable acrolein metabolitein a rat model of spinal cord injury","volume":"30","author":"Zheng","year":"2013","journal-title":"J Neurotrauma"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-170736","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:05:24Z","timestamp":1777370724000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-170736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,19]]},"references-count":55,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-170736","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,19]]}}}